Literature DB >> 15099661

Factors associated with methadone maintenance treatment retention among street-recruited injection drug users.

Robert E Booth1, Karen F Corsi, Susan K Mikulich-Gilbertson.   

Abstract

This study examined factors associated with methadone maintenance retention, defined as remaining in treatment for a minimum of 90 days, among street recruited injection drug users (IDUs). Targeted sampling methods were used to establish recruitment quotas in Denver census tracks. A total of 577 IDUs were randomly assigned to either a risk reduction intervention, focusing on safer injection and sex behaviors, or motivational interviewing, addressing more sweeping lifestyle changes including drug treatment. All subjects who wanted treatment were provided transportation, rapid intake and a waiver of the intake fee. In addition, 50% were randomly assigned a coupon for 90 days of free treatment. Overall, 33% entered treatment and of these, 60% remained for at least 90 days. Factors associated with retention included higher methadone dose, free treatment, greater contacts with the clinic and counselor rating of patient cooperation. Although desire for treatment, or motivation, was associated in univariate analyses with greater retention, there were no differences observed between the motivational interviewing and risk reduction interventions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099661     DOI: 10.1016/j.drugalcdep.2003.12.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  36 in total

1.  Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.

Authors:  Cheryl Teruya; Robert P Schwartz; Shannon Gwin Mitchell; Albert L Hasson; Christie Thomas; Samantha H Buoncristiani; Yih-Ing Hser; Katharina Wiest; Allan J Cohen; Naomi Glick; Petra Jacobs; Paul McLaughlin; Walter Ling
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

2.  A treatment reengagement intervention for syringe exchangers.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Ken Kolodner; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2011-08-09

3.  Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study.

Authors:  Barrot H Lambdin; Frank Masao; Olivia Chang; Pamela Kaduri; Jessie Mbwambo; Ayoub Magimba; Norman Sabuni; R Douglas Bruce
Journal:  Clin Infect Dis       Date:  2014-05-22       Impact factor: 9.079

4.  Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.

Authors:  Jaimee L Heffner; Giao Q Tran; Candace S Johnson; Suzan Winders Barrett; Thomas J Blom; Rachel D Thompson; Robert M Anthenelli
Journal:  J Stud Alcohol Drugs       Date:  2010-01       Impact factor: 2.582

Review 5.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

6.  Special diabetes program for Indians: retention in cardiovascular risk reduction.

Authors:  Spero M Manson; Luohua Jiang; Lijing Zhang; Janette Beals; Kelly J Acton; Yvette Roubideaux
Journal:  Gerontologist       Date:  2011-06

7.  Correlates of methadone client retention: a prospective cohort study in Guizhou province, China.

Authors:  Enwu Liu; Tao Liang; Limei Shen; Huan Zhong; Bing Wang; Zunyou Wu; Roger Detels
Journal:  Int J Drug Policy       Date:  2008-10-31

8.  Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.

Authors:  Sharon M Kelly; Kevin E Oʼgrady; Jerome H Jaffe; Devang Gandhi; Robert P Schwartz
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

9.  Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Christopher Burke; Ken Kolodner; Robert K Brooner
Journal:  Addict Behav       Date:  2010-01-04       Impact factor: 3.913

10.  Leaving buprenorphine treatment: patients' reasons for cessation of care.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Jerome H Jaffe; Kevin E O'Grady; Yngvild K Olsen; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2013-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.